Advertisement
Document › Details
Symrise AG. (5/6/19). "Press Release: Symrise Acquires Italian Biotech Company Cutech. Adds Competitive Edge in Bio-analytical Methods – Expands R&D Capacities for the Efficacy Testing of Cosmetic Ingredients".
Organisation | Symrise AG | |
Group | Symrise (Group) | |
Organisation 2 | Cutech S.r.l. | |
Group | Symrise (Group) | |
Product | preclinical research | |
Product 2 | cosmetics | |
Index term | Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise | |
Person | Schmaus, Gerhard (Symrise 201905 Head of Global Innovation Cosmetic Ingredients Division) | |
Person 2 | Pertile, Paolo (Cutech 201905 CEO + Co-Founder) | |
– Accelerates the development of active ingredients based on predictive ex vivo models
– Unique pre-clinical screening services provided to the cosmetic industry
Symrise has signed a contract to acquire the Italian biotech company Cutech in Padua. The enterprise offers unique pre-clinical screening services for cosmetic ingredients and finished formulations. The purchase will expand the expertise of Symrise in the efficacy testing of cosmetic ingredients and open new opportunities for collaboration with partners from scientific institutions. It will also increase the go-to-market speed for novel active ingredients.
“Cutech constitutes the perfect fit for Symrise’s Cosmetic Ingredients Division. The highly specific R&D and biotechnology capabilities of Cutech optimally complement the research expertise of Symrise”, says Dr. Gerhard Schmaus, Head of Global Innovation Cosmetic Ingredients Division at Symrise.
“We have decided to closer collaborate with Symrise as both partners can benefit from the union. Symrise acquires considerable know-how in the prediction of the effectiveness of cosmetic ingredients. Cutech will benefit from the broad research base at Symrise and its technological resources. This will lead to a faster development of effective cosmetic ingredients. We look forward with excitement to our joint projects,” says Dr. Paolo Pertile, CEO at Cutech.
The biotech company, founded in 2002, specializes in unique pre-clinical screening services based on innovative proprietary ex vivo skin, sebaceous gland and hair models. Cutech also contributes IP on natural ingredients, such as micro algae to supplement the Symrise portfolio.
“The joining forces of Symrise and Cutech will make the development of new proprietary analysis and prediction models for cosmetic ingredients easier and faster. Such models will strengthen the leadership of Symrise Cosmetics Ingredients and will position it one step ahead of the competition”, concludes Eder Ramos, President Cosmetic Ingredient Division. “For our customers, adding pre-clinical testing to our service portfolio will definitely constitute a plus during their product development. In addition it will also enable us to further expand our biotech network, thus accessing new, cutting-edge technologies.”
Deloitte Financial Advisory S.r.l. is acting as financial advisor to Symrise. Clifford Chance is acting as legal advisor to Symrise. Pirola Pennuto Zei & Associati is acting as legal advisor to Cutech.
Record changed: 2023-06-05 |
Advertisement
More documents for Symrise (Group)
- [1] Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi....
- [2] Symrise AG. (2/29/24). "Press Release: Dr Jean-Yves Parisot Assumes CEO Position from Dr Heinz-Jürgen Bertram". Holzminden....
- [3] Bicoll GmbH. (9/26/23). "Press Release: Bicoll GmbH Introduces Innovative Natural Sweet Modulation Patent Application". Planegg-Martinsried....
- [4] Symrise AG. (6/30/22). "Press Release: Symrise Cosmetic Ingredients Enters Strategic Partnership with Evoxx Technologies". Holzminden....
- [5] Symrise AG. (4/14/22). "Press Release: Symrise Successfully Places €750 million ESG-linked Promissory Loan Notes". Holzminden....
- [6] Symrise AG. (5/27/20). "Press Release: Symrise Opens Production Site in China"....
- [7] Symrise AG. (2/8/19). "Press Release: Symrise Successfully Completes Capital Increase. Strong Investor Demand – 5.614 Million New Shares Placed – Gross Proceeds amount of € 400 Million [Not for US, CA, AU or JP]"....
- [8] Symrise AG. (1/31/19). "Press Release: Symrise Strengthens Pet Food Activities and Expands US Footprint with Acquisition of ADF/IDF"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top